Prices of Doxycycline Hydrochloride in the United States declined notably during May xxxx, reversing the upward trend observed in April. The fall was mainly driven by falling Doxycycline Hydrochloride demand, efforts aimed at inventory rationalization, and changing trade and policy circumstances in the pharmaceutical sector.
Doxycycline Hydrochloride prices settled at USD xx,xxx/MT CFR Houston.
Market participants responded cautiously to the lingering effects of April鈥檚 tariff-related stockpiling, which had inflated inventory levels across much of the pharmaceutical supply chain including key antibiotics like Doxycycline Hydrochloride. Despite a mid-May trade de-escalation between the United States and China, which offered short-term tariff relief, a general atmosphere of caution prevailed as businesses reassessed procurement strategies under the new cost and regulatory realities.听
Following April x notification of a xxxx tariff on imports of Chinese drugs, some U.S. importers pre-stocked before...
